Evidence map›Paper›PMID 10024516›Full record

ArticleThe Biochemical journal1999

Characterization of the interaction domains of Ure2p, a prion-like protein of yeast.

E Fernandez-Bellot, E Guillemet, A Baudin-Baillieu, S Gaumer, A A Komar, C Cullin

Abstract read
In one paragraph

Article in The Biochemical journal, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Conservation of a portion of the S. cerevisiae Ure2p prion domain that interacts with the full-length protein.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  7. Article
  8. Article
  9. The crystal structure of the nitrogen regulation fragment of the yeast prion protein Ure2p.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  10. Prions in Saccharomyces and Podospora spp.: protein-based inheritance.Microbiology and molecular biology reviews : MMBR · 1999
    Review
  11. Two prion-inducing regions of Ure2p are nonoverlapping.Molecular and cellular biology · 1999
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

E Fernandez-BellotCentre de Génétique Moléculaire du C.N.R.S., Laboratoire Propre Associé à l'Université Pierre-et-Marie-Curie, 91190 Gif-sur-Yvette, France.
E Guillemet
A Baudin-Baillieu
S Gaumer
A A Komar
C Cullin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the yeast Saccharomyces cerevisiae, the non-Mendelian inherited genetic element [URE3] behaves as a prion. A hypothesis has been put forward which states that [URE3] arises spontaneously from its cellular isoform Ure2p (the product of the URE2 gene), and propagates through interactions of the N-terminal domain of the protein, thus leading to its aggregation and loss of function. In the present study, various N- and C-terminal deletion mutants of Ure2p were constructed and their cross-interactions were tested in vitro and in vivo using affinity binding and a two-hybrid analysis. We show that the self-interaction of the protein is mediated by at least two domains, corresponding to the first third of the protein (the so-called prion-forming domain) and the C-terminal catalytic domain.

Indexed as

Saccharomyces cerevisiae ProteinsCatalytic DomainFungal ProteinsGlutathione PeroxidasePrionsProtein BindingSaccharomyces cerevisiaeFungal ProteinsGlutathione PeroxidasePrionsSaccharomyces cerevisiae ProteinsURE2 protein, S cerevisiae

Identifiers

PMID10024516
PMCPMC1220066

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.